Ling Lin

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.

Ye-ming Wang, Xiaoying Gu, Jiuyang Xu, 2024, New England Journal of Medicine.

Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial

F. Lin, Yanan Tang, Wenhao Yan, 2024, EClinicalMedicine.